Clinical Trials in Nashville

Showing 11121-11140 of 17,403 trials

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

NCT02285920

The SPin-D Trial is a phase II randomized, double-blind, placebo-controlled, multi-center study of spironolactone (SPL) for patients with hemodialysis-dependent end-stage renal disease.

End-Stage Renal Disease

University of Pennsylvania129 participantsStarted Nov 2014

Washington D.C., District of Columbia, United States • Boston, Massachusetts, United States • Nashville, Tennessee, United States +1 more locations

COMPLETEDPhase 2< 1 mile

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

NCT01439568

The purpose of this trial is to compare the progression free survival of LY2510924 + carboplatin + etoposide therapy versus carboplatin + etoposide therapy in participants with extensive-stage disease small cell lung cancer (SCLC)

Extensive Stage Small Cell Lung Carcinoma

Eli Lilly and Company90 participantsStarted Sep 2011

Denver, Colorado, United States • Fort Myers, Florida, United States • Orlando, Florida, United States +12 more locations

Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

Find Trials by Condition in Nashville

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Efficacy and Safety Study of SPL7013 Gel to Prevent the Recurrence of Bacterial Vaginosis (BV)

Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA

Study of Mepolizumab Safety Syringe in Asthmatics

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Head-to-Head Study of Etelcalcetide (AMG 416) and Cinacalcet

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer

Bevacizumab and Temsirolimus in Treating Patients With Recurrent or Persistent Endometrial Cancer

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

An Extension Study to Assess Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD)

Expanded Treatment Protocol (ETP) of Ruxolitinib in Patients With Polycythemia Vera Who Were Hydroxyurea Resistant or Intolerant and for Whom no Treatment Alternatives Was Available.